Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Surrozen ( (SRZN) ).
On October 14, 2025, Surrozen, Inc. was informed by TCGFB, Inc. of the termination of their Collaboration Agreement, effective November 13, 2025. The agreement, established on October 31, 2024, involved Surrozen providing antibody discovery services, while TCGFB managed the intellectual property related to TGF-β products. The termination, executed for convenience, incurs no penalties for either party. Surrozen was to receive up to $6 million and a warrant for TCGFB shares under certain conditions. This agreement was a related party transaction due to shared affiliations with The Column Group.
The most recent analyst rating on (SRZN) stock is a Buy with a $32.00 price target. To see the full list of analyst forecasts on Surrozen stock, see the SRZN Stock Forecast page.
Spark’s Take on SRZN Stock
According to Spark, TipRanks’ AI Analyst, SRZN is a Neutral.
Surrozen’s overall stock score reflects significant financial challenges, including consistent losses and a weak balance sheet. While recent corporate events, such as the private placement, provide a positive outlook for liquidity, the technical indicators and valuation suggest caution. The company needs to address its financial instability and improve cash flow management to enhance its stock performance.
To see Spark’s full report on SRZN stock, click here.
More about Surrozen
Average Trading Volume: 20,146
Technical Sentiment Signal: Buy
Current Market Cap: $116.6M
Learn more about SRZN stock on TipRanks’ Stock Analysis page.